0

Travel Vaccines Market by Disease Type and Geography - Forecast and Analysis 2022-2026

  • Published: Jun 2022
  • Pages: 138
  • SKU: IRTNTR70539
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The travel vaccines market share is expected to increase to USD 2.44 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.59%.

This travel vaccines market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers travel vaccines market segmentation by disease type (influenza, diptheria, hepatitis, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The travel vaccines market report also offers information on several market vendors, including Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE among others.

What will the Travel Vaccines Market Size be During the Forecast Period?

Travel Vaccines Market Size

Download the Free Report Sample to Unlock the Travel Vaccines Market Size for the Forecast Period and Other Important Statistics

 

Travel Vaccines Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The increase in global migration is notably driving the travel vaccines market growth, although factors such as absence of coverage for travel vaccines in many health plans may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the travel vaccines industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Travel Vaccines Market Driver

One of the key factors driving the global travel vaccines market growth is the increase in global travel and migration. An increase in travel and migration has resulted in the spread of pathogens and disease-causing vectors worldwide. Moreover, the growing contact of people with different animals and plants has also resulted in the movement of pathogens from them to people. For instance, the H5N1 avian flu virus was first discovered in poultry (geese) in China and later spread to people. Although the travel restrictions, coupled with the growing incidence of COVID-19 in various countries across the globe, limited traveling and migration activities, especially in 2020. However, these activities are expected to increase in the coming years. Therefore, the increase in global travel and tourism, as well as migration, offers huge opportunities for the manufacturers of vaccines to invest in the R&D of new and more effective vaccines, which will propel market growth.

Key Travel Vaccines Market Trend

Changes in the demographic profile of travelers globally is one of the key travel vaccines market trends that is expected to impact the industry positively in the forecast period. The success of achieving travel vaccine compliance depends on the demographic profile of travelers. For instance, travelers who are migrants have fewer chances of being vaccinated. Another trend that affects the chances of being immunized before travel is the age of the traveler. People belonging to the younger age group (less than 30 years) are the ones who generally opt for traveling as per the current trends, and this part of the population has higher chances of taking advice on travel-related vaccinations and getting themselves immunized. However, this situation is expected to recover, and the expected growth in immigration, coupled with the demand for vaccination for immunization against infectious diseases among all age groups, as per the regulatory mandates, is likely to boost the growth of the concerned market in the coming years.

Key Travel Vaccines Market Challenge

One of the key challenges to the global travel vaccines market growth is the absence of coverage for travel vaccines in many health plans. Many travelers do not follow the health authority's recommendations to get vaccinated against vaccine-preventable diseases, mainly because of the high cost of the vaccine and the non-coverage of travel vaccines by health insurance plans such as Medicare. Many health insurance plans do not cover the cost of vaccinations required before traveling as the insurer or insurance company considers these vaccinations as electives. In the US, the cost of travelers getting vaccinated at a travel clinic includes an initial consultation fee of USD 100, and depending on the disease and the vaccine, administering the shot costs USD 50 to USD 1,000 or even more. Since these costs are not covered by health insurance, many people do not opt to get vaccinated, which may hamper the market growth during the forecast period.

This travel vaccines market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global travel vaccines market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the travel vaccines market during the forecast period.

Who are the Major Travel Vaccines Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Altimmune Inc.
  • AstraZeneca Plc
  • Bharat Biotech Ltd.
  • CSL Ltd.
  • Dynavax Technologies Corp.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • KM Biologics Co. Ltd.
  • LG Chem Ltd.
  • Merck and Co. Inc.
  • Mitsubishi Chemical Holdings Corp.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • Sinovac Biotech Ltd.
  • SK Chemicals Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva SE

 

This statistical study of the travel vaccines market encompasses successful business strategies deployed by the key vendors. The travel vaccines market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

  • CSL Ltd. - The company offers the broadest influenza vaccine and a wide range of vaccines and specialty medicines that meet unique, local public health needs.
  • Bharat Biotech Ltd. - The company offers travel vaccines such as BioHib, a lyophilized vaccine that is used for development based on an Indian strain.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The travel vaccines market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Travel Vaccines Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the travel vaccines market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Travel Vaccines Market?

Travel Vaccines Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market's growth will originate from North America during the forecast period. The US is the key market for travel vaccines in North America. Market growth in this region will be faster than the growth of the market in the Rest of World (ROW).

Increasing access to vaccines against diseases and a growing number of initiatives to generate awareness about immunization programs will facilitate the travel vaccines market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

North American countries have been severely affected by the outbreak of the COVID-19 pandemic, mainly in 2020. For instance, according to the data published by the CDC, the reported number of COVID-19 cases in the US increased from 33,404 on March 23, 2020, to 30,662,171 on April 7, 2021. However, during the forecast period, the regional market is expected to recover and witness stable growth, owing to various factors such as the expected increase in travel, the growing focus of the manufacturers on developing new dosages of travel vaccines for better protection, and rising demand for increasing the volume of travel vaccines to fulfill the growing demand.

What are the Revenue-generating Disease Type Segments in the Travel Vaccines Market?

Travel Vaccines Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The travel vaccines market share growth by the influenza segment will be significant during the forecast period. The growing demand for influenza vaccines by the end-user facilities coupled with the rise in traveling rate will drive the segment growth in the coming years. There are multiple vendors operating in the global travel vaccines market for influenza, some of whom are the top and most well-established players in the vaccines market, such as GlaxoSmithKline Plc, Sanofi SA (Sanofi), and CSL Ltd. (CSL), which contribute significantly to the global travel vaccines market for influenza. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the travel vaccines market size and actionable market insights on post COVID-19 impact on each segment.

Vaccines Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 8.59%

Market growth 2022-2026

$ 2.44 billion

Market structure

Fragmented

YoY growth (%)

7.85

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Germany, UK, Japan, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Travel Vaccines Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive travel vaccines market growth during the next five years
  • Precise estimation of the travel vaccines market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the travel vaccines industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of travel vaccines market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Disease Type

    • 5.1 Market segments
      • Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
    • 5.2 Comparison by Disease Type
      • Exhibit 26: Chart on Comparison by Disease Type
      • Exhibit 27: Data Table on Comparison by Disease Type
    • 5.3 Influenza - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Influenza - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Influenza - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Influenza - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Influenza - Year-over-year growth 2021-2026 (%)
    • 5.4 Diptheria - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Diptheria - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Diptheria - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Diptheria - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Diptheria - Year-over-year growth 2021-2026 (%)
    • 5.5 Hepatitis - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Hepatitis - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Hepatitis - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Hepatitis - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Hepatitis - Year-over-year growth 2021-2026 (%)
    • 5.6 Others - Market size and forecast 2021-2026
      • Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.7 Market opportunity by Disease Type
      • Exhibit 44: Market opportunity by Disease Type ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 46: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 48: Chart on Geographic comparison
      • Exhibit 49: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 Japan - Market size and forecast 2021-2026
      • Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.11 China - Market size and forecast 2021-2026
      • Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 86: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 89: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 90: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 91: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 92: Matrix on vendor position and classification
            • 10.3 Bharat Biotech Ltd.
              • Exhibit 93: Bharat Biotech Ltd. - Overview
              • Exhibit 94: Bharat Biotech Ltd. - Product / Service
              • Exhibit 95: Bharat Biotech Ltd. - Key news
              • Exhibit 96: Bharat Biotech Ltd. - Key offerings
            • 10.4 CSL Ltd.
              • Exhibit 97: CSL Ltd. - Overview
              • Exhibit 98: CSL Ltd. - Business segments
              • Exhibit 99: CSL Ltd. - Key news
              • Exhibit 100: CSL Ltd. - Key offerings
              • Exhibit 101: CSL Ltd. - Segment focus
            • 10.5 GlaxoSmithKline Plc
              • Exhibit 102: GlaxoSmithKline Plc - Overview
              • Exhibit 103: GlaxoSmithKline Plc - Business segments
              • Exhibit 104: GlaxoSmithKline Plc - Key news
              • Exhibit 105: GlaxoSmithKline Plc - Key offerings
              • Exhibit 106: GlaxoSmithKline Plc - Segment focus
            • 10.6 Merck and Co. Inc.
              • Exhibit 107: Merck and Co. Inc. - Overview
              • Exhibit 108: Merck and Co. Inc. - Business segments
              • Exhibit 109: Merck and Co. Inc. - Key news
              • Exhibit 110: Merck and Co. Inc. - Key offerings
              • Exhibit 111: Merck and Co. Inc. - Segment focus
            • 10.7 Mitsubishi Chemical Holdings Corp.
              • Exhibit 112: Mitsubishi Chemical Holdings Corp. - Overview
              • Exhibit 113: Mitsubishi Chemical Holdings Corp. - Business segments
              • Exhibit 114: Mitsubishi Chemical Holdings Corp. - Key offerings
              • Exhibit 115: Mitsubishi Chemical Holdings Corp. - Segment focus
            • 10.8 Pfizer Inc.
              • Exhibit 116: Pfizer Inc. - Overview
              • Exhibit 117: Pfizer Inc. - Product / Service
              • Exhibit 118: Pfizer Inc. - Key news
              • Exhibit 119: Pfizer Inc. - Key offerings
            • 10.9 Sanofi
              • Exhibit 120: Sanofi - Overview
              • Exhibit 121: Sanofi - Business segments
              • Exhibit 122: Sanofi - Key news
              • Exhibit 123: Sanofi - Key offerings
              • Exhibit 124: Sanofi - Segment focus
            • 10.10 Serum Institute of India Pvt. Ltd.
              • Exhibit 125: Serum Institute of India Pvt. Ltd. - Overview
              • Exhibit 126: Serum Institute of India Pvt. Ltd. - Product / Service
              • Exhibit 127: Serum Institute of India Pvt. Ltd. - Key offerings
            • 10.11 SK Chemicals Co. Ltd.
              • Exhibit 128: SK Chemicals Co. Ltd. - Overview
              • Exhibit 129: SK Chemicals Co. Ltd. - Business segments
              • Exhibit 130: SK Chemicals Co. Ltd. - Key offerings
              • Exhibit 131: SK Chemicals Co. Ltd. - Segment focus
            • 10.12 Takeda Pharmaceutical Co. Ltd.
              • Exhibit 132: Takeda Pharmaceutical Co. Ltd. - Overview
              • Exhibit 133: Takeda Pharmaceutical Co. Ltd. - Product / Service
              • Exhibit 134: Takeda Pharmaceutical Co. Ltd. - Key news
              • Exhibit 135: Takeda Pharmaceutical Co. Ltd. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 136: Inclusions checklist
                • Exhibit 137: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 138: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 139: Research methodology
                • Exhibit 140: Validation techniques employed for market sizing
                • Exhibit 141: Information sources
              • 11.5 List of abbreviations
                • Exhibit 142: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Travel Vaccines Market market growth will increase by $2.44 billion during 2022-2026.
              The travel vaccines market market is expected to grow at a CAGR of 8.59% during 2022-2026.
              Technavio has segmented the travel vaccines market market by other 1 (Influenza, Diptheria, Hepatitis, and Others) and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., Valneva SE are a few of the key vendors in the travel vaccines market market.
              North America will register the highest growth rate of 42% among the other regions. Therefore, the travel vaccines market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the travel vaccines market market growth are:
              • Increase in global migration
              • Changes in the demographic profile of travelers globally
              The travel vaccines market market vendors should focus on grabbing business opportunities from the influenza segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>